Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod

77
7
Favorite

Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod

Bloomberg2022-09-01

Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

kevinlaisq
·2022-09-02
Pls like
Reply
Like
Report
j2o777
·2022-09-02
Good
Reply
1
Report
HermioneG
·2022-09-01
Awesome!
Reply
1
Report
ACJC
·2022-09-01
sure
Reply
3
Report
Trainman
·2022-09-01
Pump up the sales
Reply
1
Report
MoneyCentral
·2022-09-01
Another round
Reply
2
Report
NPC69
·2022-09-01
K
Reply
4
Report
Fold Replies
- sunshine138:
  ok
  2022-09-01
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1123051917?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-01 22:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123051917","market":"us","top_or_hot":-1,"title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","media":"Bloomberg","content":"<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","article_id":"1123051917","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","pubTimestamp":1662041216,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"translate_title":"辉瑞变体目标Covid助推器获得欧盟首肯","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"PFE":0.9},"content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9939800626,"gmtCreate":1662080513468,"gmtModify":1676536802365,"author":{"id":"3572874548548490","authorId":"3572874548548490","name":"kevinlaisq","avatar":"https://static.tigerbbs.com/329de1199f764a89b7cadf50308e183d","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3572874548548490","authorIdStr":"3572874548548490"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939800626","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939116316,"gmtCreate":1662076787838,"gmtModify":1676536800469,"author":{"id":"4123765410692892","authorId":"4123765410692892","name":"j2o777","avatar":"https://community-static.tradeup.com/news/58a6309af783f2b7b1f81ece317027cc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4123765410692892","authorIdStr":"4123765410692892"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939116316","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939942211,"gmtCreate":1662046370335,"gmtModify":1676536788410,"author":{"id":"3581581151725380","authorId":"3581581151725380","name":"HermioneG","avatar":"https://static.tigerbbs.com/449ae31dcb8cfcd4dcedab9bc5dec8aa","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581581151725380","authorIdStr":"3581581151725380"},"htmlText":"Awesome!","listText":"Awesome!","text":"Awesome!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939942211","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939959160,"gmtCreate":1662045063251,"gmtModify":1676536759418,"author":{"id":"4123731062636402","authorId":"4123731062636402","name":"ACJC","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4123731062636402","authorIdStr":"4123731062636402"},"htmlText":"sure","listText":"sure","text":"sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939959160","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939920048,"gmtCreate":1662043698186,"gmtModify":1676536726926,"author":{"id":"4094982368358060","authorId":"4094982368358060","name":"Trainman","avatar":"https://static.tigerbbs.com/7e9b4a5cf72b92493d595c02fc199220","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":1,"idStr":"4094982368358060","authorIdStr":"4094982368358060"},"htmlText":"Pump up the sales","listText":"Pump up the sales","text":"Pump up the sales","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939920048","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939961138,"gmtCreate":1662042780427,"gmtModify":1676536720538,"author":{"id":"4091678983335410","authorId":"4091678983335410","name":"MoneyCentral","avatar":"https://static.tigerbbs.com/b65487e9bb510d46c3ac12f7427011cb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091678983335410","authorIdStr":"4091678983335410"},"htmlText":"Another round","listText":"Another round","text":"Another round","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939961138","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9939987384,"gmtCreate":1662042367651,"gmtModify":1676536717778,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3584779133668268","authorIdStr":"3584779133668268"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9939987384","repostId":1123051917,"repostType":4,"repost":{"id":"1123051917","kind":"news","pubTimestamp":1662041216,"share":"https://ttm.financial/m/news/1123051917?lang=&edition=fundamental","pubTime":"2022-09-01 22:06","market":"us","language":"en","title":"Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=1123051917","media":"Bloomberg","summary":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer","content":"<html><head></head><body><p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.</p><p>The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.</p><p>Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.</p><p>The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”</p><p>The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”</p><p>A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.</p><p>The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.</p><p>The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.</p><p>Last month the UK became the first country in the world to clear an omicron targeting shot.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer Variant-Targeting Covid Boosters Get EU Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-01 22:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2022-09-01/moderna-pfizer-variant-targeting-covid-boosters-get-eu-nod?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123051917","content_text":"Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent.The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.Health authorities around the world are seeking to bolster and broaden protection for people at greater risk of severe disease and death from infection by omicron variants. As the virus has mutated it has been able to sidestep existing immunity from early vaccination and infections caused by earlier strains.The EMA said Europe wants to have a broad range of adapted vaccines that target different variants so member states “have a plurality of options to meet their needs when they design their vaccination strategies.”The approval of the BA.1 vaccines is a “quantum leap in the fight against the pandemic,” said German Health Minister Karl Lauterbach, adding that now is the optimal time to close the vaccine gap for the fall. “Now vaccines can be used that work very well against all the known virus variants.”A formal approval and recommendation by the European Commission, the executive body of the European Union, is expected later this week.The agency is expected in the coming weeks to also issue opinions on two other bivalent vaccines from Pfizer-BioNTech and Moderna that target the dominant BA.4 and BA.5 subvariants, Stella Kyriakides, the EU health commissioner, said in a statement.The US has already approved the two firms’ boosters targeting the BA.4 and BA.5 variants.Last month the UK became the first country in the world to clear an omicron targeting shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":103721663,"gmtCreate":1662045649856,"gmtModify":1663257954429,"authorId":3586655655659820,"author":{"id":3586655655659820,"idStr":"3586655655659820","authorId":3586655655659820,"name":"sunshine138","avatar":"https://static.tigerbbs.com/23149c63a63bfeec1572cc27e1322750","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9939987384,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":77,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}